Developing technology to collect and analyze airborne viruses from breath samples
Microcyclone arrays for high resolution bioaerosol fractionation and viable virus collection
['FUNDING_R21'] · UNIV OF MARYLAND, COLLEGE PARK · NIH-10757044
This study is testing a new technology that helps collect and analyze tiny particles from breath to better understand how respiratory viruses, like the flu, spread, which could lead to better ways to study and prevent infections.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF MARYLAND, COLLEGE PARK (nih funded) |
| Locations | 1 site (COLLEGE PARK, UNITED STATES) |
| Trial ID | NIH-10757044 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a new technology using microscale cyclone arrays to efficiently collect and analyze bioaerosols, specifically targeting respiratory viruses like influenza. By isolating different sizes of aerosol particles from exhaled breath, researchers aim to better understand how these viruses spread and behave in the environment. The technology utilizes advanced 3D printing techniques to produce complex structures that enhance the collection process, allowing for more precise studies of viral infectivity. This innovative approach could lead to improved methods for studying respiratory infections and their transmission.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are infected with respiratory viruses, particularly those with influenza.
Not a fit: Patients who do not have respiratory infections or are not exposed to airborne viruses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of respiratory viral infections, potentially improving public health responses.
How similar studies have performed: While the approach of using microscale cyclone technology is innovative, similar methods for studying airborne pathogens have shown promise in other research contexts.
Where this research is happening
COLLEGE PARK, UNITED STATES
- UNIV OF MARYLAND, COLLEGE PARK — COLLEGE PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DEVOE, DON L — UNIV OF MARYLAND, COLLEGE PARK
- Study coordinator: DEVOE, DON L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.